Published in J Immunol on January 01, 2000
Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol (2010) 2.67
OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med (2003) 2.26
The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev (2009) 1.70
OX40 is a potent immune-stimulating target in late-stage cancer patients. Cancer Res (2013) 1.57
T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest (2005) 1.45
The role of OX40-mediated co-stimulation in T-cell activation and survival. Crit Rev Immunol (2009) 1.39
Science gone translational: the OX40 agonist story. Immunol Rev (2011) 1.39
A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med (2003) 1.35
T cell apoptosis and reactive oxygen species. J Clin Invest (2003) 1.35
OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J Immunol (2008) 1.12
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice. J Immunother (2010) 1.10
Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy. ISRN Oncol (2013) 1.04
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo. Eur J Immunol (2009) 1.03
All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology (2001) 1.02
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol (2009) 1.01
Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma. Blood (2011) 1.01
A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. J Clin Invest (2003) 0.99
Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering. Proc Natl Acad Sci U S A (2003) 0.98
Understanding how lipopolysaccharide impacts CD4 T-cell immunity. Crit Rev Immunol (2008) 0.96
Regulating functional cell fates in CD8 T cells. Immunol Res (2010) 0.95
Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF. J Immunol (2009) 0.93
CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis. Arthritis Res Ther (2005) 0.92
MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. Glycoconj J (2003) 0.91
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects. Curr Mol Med (2009) 0.91
4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. Immunology (2004) 0.91
Modulation of antitumor responses by dendritic cells. Springer Semin Immunopathol (2005) 0.91
Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis. Rheumatol Int (2008) 0.89
A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory. J Immunol (2013) 0.89
T cell responses: naive to memory and everything in between. Adv Physiol Educ (2013) 0.89
Type I IFN-dependent T cell activation is mediated by IFN-dependent dendritic cell OX40 ligand expression and is independent of T cell IFNR expression. J Immunol (2011) 0.85
OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival. Eur J Immunol (2011) 0.85
CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion. Immunol Cell Biol (2013) 0.84
Review article: molecular signals and genetic reprogramming in peripheral T-cell differentiation. Immunology (2000) 0.84
OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity. Int J Cancer (2009) 0.83
TNF superfamily: costimulation and clinical applications. Cell Biol Int (2009) 0.83
Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation. Oncoimmunology (2013) 0.82
Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized mice. Cancer Immunol Res (2014) 0.81
A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen. J Immunol (2013) 0.81
The role of CARMA1 in T cells. Crit Rev Immunol (2013) 0.81
Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations. J Clin Immunol (2004) 0.81
The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease. Immunology (2008) 0.80
Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension. BMC Immunol (2011) 0.80
OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection. J Infect Dis (2012) 0.80
Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity. Curr Immunol Rev (2005) 0.79
Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis. Inflamm Res (2012) 0.79
Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response. Immunology (2003) 0.79
Pimecrolimus inhibits up-regulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogeneic dendritic cells. Clin Exp Immunol (2002) 0.78
Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2. Cell Mol Immunol (2015) 0.78
Separate roles for antigen recognition and lymph node inflammation in CD8+ memory T cell formation. J Immunol (2010) 0.76
OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer. Oncotarget (2015) 0.76
Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too? Expert Opin Biol Ther (2016) 0.75
Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production. J Leukoc Biol (2017) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun (1995) 4.33
Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun (2000) 2.55
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25
Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol (1991) 2.15
Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol (1999) 1.95
The future of scattered trees in agricultural landscapes. Conserv Biol (2008) 1.92
IL-6 rescues resting mouse T cells from apoptosis. J Immunol (1997) 1.89
Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun (1998) 1.86
Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin Diagn Lab Immunol (2000) 1.67
Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol (1999) 1.64
Effects of a medical team coordinator on length of hospital stay. CMAJ (1992) 1.61
Effect of prenatal dexamethasone on rat renal development. Kidney Int (2001) 1.58
Localized antimicrobial peptide expression in human gingiva. J Periodontal Res (2001) 1.58
Studies on EB virus of Burkitt's lymphoblasts. Virology (1969) 1.57
Continuing medical education: does it address prevention? J Community Health (1982) 1.53
Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol (1997) 1.52
Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res (2005) 1.50
CSF and MRI findings in patients with acute herpes zoster. Neurology (1998) 1.49
Giant melanoma of the inner thigh: a homeopathic life-threatening negligence. Ann Plast Surg (1991) 1.48
Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res (2000) 1.46
OX-40: life beyond the effector T cell stage. Semin Immunol (1998) 1.43
Two decades of abdominal aortic aneurysm repair: have we made any progress? J Vasc Surg (2000) 1.42
The inframammary midline triangle in reduction mammaplasty: the renewal of an old idea. Plast Reconstr Surg (1994) 1.40
A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg (1997) 1.37
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob Agents Chemother (2001) 1.36
Immunization of HIV-infected children with varicella vaccine. J Pediatr (2001) 1.35
Interbacterial binding among strains of pathogenic and commensal oral bacterial species. Oral Microbiol Immunol (1996) 1.33
Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun (1994) 1.30
Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis (2003) 1.27
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother (2000) 1.27
Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci U S A (1997) 1.25
Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4. J Immunol (2001) 1.23
Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob Agents Chemother (1999) 1.20
A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J Clin Invest (1993) 1.17
Inhibition of superoxide production in human polymorphonuclear leukocytes by oral treponemal factors. Infect Immun (1988) 1.13
Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infection. J Immunol (1986) 1.13
Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns. Burns (1998) 1.11
CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J Immunol (1999) 1.11
Late complications of the modified Indiana pouch. J Urol (1994) 1.10
Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol (2001) 1.08
Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant (2007) 1.07
Early preferential stimulation of gamma delta T cells by TNF-alpha. J Immunol (1998) 1.05
[The mallet finger in children and adolescents]. Handchir Mikrochir Plast Chir (2008) 1.05
Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol (2000) 1.05
[Pelvic fractures: epidemiology, therapy and long-term outcome. Overview of the multicenter study of the Pelvis Study Group]. Unfallchirurg (1996) 1.05
The varicella-autoantibody syndrome. Pediatr Res (2001) 1.04
Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am J Surg (1997) 1.03
Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin Infect Dis (2001) 1.03
Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. Antimicrob Agents Chemother (1998) 1.03
Ubiquitin carrier protein-catalyzed ubiquitin transfer to histones. Mechanism and specificity. J Biol Chem (1988) 1.02
Levels of active ubiquitin carrier proteins decline during erythroid maturation. J Biol Chem (1988) 1.01
Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01
Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates. J Clin Microbiol (1998) 1.00
Mobile rRNA methylase genes coding for erythromycin resistance in Actinobacillus actinomycetemcomitans. J Antimicrob Chemother (1996) 1.00
Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr (1996) 0.99
Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs. J Virol (1987) 0.97
Expression of the antimicrobial peptide, human beta-defensin 1, in duct cells of minor salivary glands and detection in saliva. J Dent Res (2000) 0.97
Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol (1997) 0.96
Surface tension: floater clustering in a standing wave. Nature (2005) 0.96
Selective induction of human beta-defensin mRNAs by Actinobacillus actinomycetemcomitans in primary and immortalized oral epithelial cells. Oral Microbiol Immunol (2003) 0.96
Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg (1999) 0.95
Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide. Transpl Infect Dis (2006) 0.95
Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant (1998) 0.94
Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Pediatr Infect Dis J (2001) 0.93
Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient. Burns (1991) 0.93
Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg (2000) 0.92
Lipoproteins of Treponema denticola: their effect on human polymorphonuclear neutrophils. J Periodontal Res (1997) 0.91
Chemical burn due to contact with soda lime on the playground: a potential hazard for football players. Burns (1993) 0.90
Characterization of tetracycline resistance in Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol (1995) 0.90
Myelin basic protein specific T-helper cells induce experimental anterior uveitis. J Neurosci Res (1996) 0.90
(C3) The oral epithelial cell and first encounters with HIV-1. Adv Dent Res (2006) 0.89
Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease. Eur J Cancer (1978) 0.89
Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis. Cell Immunol (1999) 0.89
Characterization of erythromycin resistance in Campylobacter (Wolinella) rectus. Clin Infect Dis (1995) 0.88
Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes. J Infect Dis (1998) 0.88
Direct detection of Porphyromonas gingivalis in Macaca fascicularis dental plaque samples using an oligonucleotide probe. J Periodontol (1994) 0.88
Feeding by the tick, Ixodes scapularis, causes CD4(+) T cells responding to cognate antigen to develop the capacity to express IL-4. Parasite Immunol (2007) 0.88
Effect of arginine deprivation on macromolecular processes in Burkitt's lymphoblasts. Exp Cell Res (1970) 0.88
Mobile rRNA methylase genes in Campylobacter (Wolinella) rectus. J Antimicrob Chemother (1995) 0.88
Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. J Clin Microbiol (2001) 0.87
[Optimal timing for secondary surgery in polytrauma patients: an evaluation of 4,314 serious-injury cases]. Chirurg (1999) 0.87
Management of the dislocated crystalline lens with a perfluorocarbon liquid. Am J Ophthalmol (1991) 0.86
Warfarin skin necrosis: local and systemic factors. Br J Plast Surg (2000) 0.86
Enzyme linked immunosorbent assay: determination of anti-adenovirus antibodies in an infant population. Rev Inst Med Trop Sao Paulo (1990) 0.86
Measurement of induced cytokines in AIDS clinical trials using whole blood: a preliminary report. ACTG Inducible Cytokines Focus Group. AIDS Clinical Trials Group. Clin Diagn Lab Immunol (1998) 0.86
Symptoms of attention-deficit hyperactivity disorder in an Italian school sample: findings of a pilot study. J Am Acad Child Adolesc Psychiatry (1993) 0.86
OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo. Cell Immunol (2001) 0.86
Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: contribution of 4-1BB during inflammatory responses. Immunol Lett (2001) 0.85
Inflammatory cells and bacteria in pericoronal exudates from acute pericoronitis. Int J Oral Maxillofac Surg (1986) 0.85
Donor-to-host transmission of Mycoplasma hominis in lung allograft recipients. Clin Infect Dis (1996) 0.84
Acyclovir-resistant neonatal herpes simplex virus infection of the larynx. J Pediatr (1994) 0.84
Immunohistochemical analysis of primary breast tumors and tumor-draining lymph nodes by means of the T-cell costimulatory molecule OX-40. Am J Surg (2000) 0.83
Melanoma of the scalp: the invisible killer. Plast Reconstr Surg (1995) 0.83
Chest wall deformity following maximal tissue expansion for breast reconstruction. Ann Plast Surg (1996) 0.83
Cross-lip vermilion "tri-tailed" flap to correct the "whistling lip" deformity. Plast Reconstr Surg (1999) 0.83
Acute genital infection in guinea pigs: effect of recombinant interleukin-2 on herpes simplex virus type 2. J Infect Dis (1986) 0.82
Evaluation of a comprehensive cardiovascular curriculum. J Sch Health (1981) 0.82